M-9831

N/A

Report date: 2024/01/02 20:03:52
NME

Base Information

Drug NameM-9831
Drug Alias NameVX-984M-9831
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA-dependent protein kinase inhibitorsDNA damage modulators
TargetsDNA-dependent protein kinase
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVertex Pharmaceuticals Incorporated
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEmd Serono Research & Development Institute IncMerck KGaA, Darmstadt, Germany
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A